Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of Tarceva in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas : Relationship Between Skin Rash and Survival

NCT00461708 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00461708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00461708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of Tarceva in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas : Relationship Between Skin Rash and Survival
Lead sponsor
Hoffmann-La Roche
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
November 30, 2010
Enrollment
153 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer